News

Avella Newsroom

January 1, 1970|
Avella CEO Letter Regarding Direct and Indirect Remuneration (DIR) Fees
March 29, 2017| CATEGORIES: Specialty Pharmacy , Press Release

Calling on Centers for Medicare & Medicaid Services to Curb Below-Cost Reimbursement to Specialty Pharmacies by Pharmaceutical Benefit Managers, to Clarify Medicare Definitions, & Promote Accurate & Responsible Reimbursement

Direct & Indirect Remuneration (DIR) fees erode access to vital clinical services & breakthrough drugs for the most vulnerable Americans, increasing costs across the board & negatively impacting seniors & their caregivers, pharmacies, & taxpayers that fund Medicare

Last week, Frier Levitt, LLC; and the National Association of Specialty Pharmacy (NASP) published a white paper describing the advent and negative consequences of Direct and Indirect Remuneration (DIR) fees. America’s seniors need the Centers for Medicare and Medicaid Services (CMS) to take immediate action to stop Pharmaceutical Benefits Managers (PBMs) from levying inappropriate, unreasonable and unsustainable DIR fees on specialty pharmacies.

Avella and mscripts to present mobile health study findings at the 2015 Armada Specialty Pharmacy Summit
April 14, 2015| CATEGORIES: Corporate , Press Release

Joint presentation will discuss the value of technology-enabled adherence strategies

Executives from Avella Specialty Pharmacy and mscripts, a leading mobile health provider, will present findings from a compelling new study on medication adherence at the 2015 Armada Specialty Pharmacy Summit on Thursday, May 7.

Avella Specialty Pharmacy Unveils its Third Issue of Dispensing Excellence
November 3, 2014| CATEGORIES: Corporate , Press Release

Publication is filled with informative articles on the latest trends, opportunities and challenges related to specialty drugs

Avella Specialty Pharmacy has just released its third issue of Dispensing Excellence, a publication aimed at healthcare providers, nurses, medical assistants and their patients. The 28-page magazine is distributed by Avella in order to share insight on the latest trends and developments in the world of specialty drugs as well as the conditions they help manage. 

Avella Specialty Pharmacy Achieves Accreditation Through ACHC
October 2, 2014| CATEGORIES: Corporate , Press Release

Avella is proud to announce that it has achieved accreditation as a specialty pharmacy through Accreditation Commission for Health Care (ACHC).

Avella among a group of specialty pharmacies now ready to distribute a new medication for adults with active psoriatic arthritis
March 27, 2014| CATEGORIES: Corporate , Press Release

Otezla® (apremilast) is the first oral therapy FDA approved to improve signs and symptoms including physical functioning for patients with this condition.

Just days after the Food and Drug Administration approved Otezla, a new oral therapy to treat active psoriatic arthritis (PsA) in adult patients, Avella has announced that it is prepared to begin distributing the drug. At this time, Avella is one of a select number of pharmacies that are contracted by Celgene, the drug manufacturer, to dispense the product at launch.

Avella Registers as an “Outsourcing Facility” with the FDA
March 18, 2014| CATEGORIES: Corporate , Press Release

New program aims to help providers identify compounding facilities that meet more rigorous standards around quality and patient safety.

Avella Specialty Pharmacy has announced that it has registered with the FDA as an Outsourcing Facility for sterile compounding as outlined in the recently enacted Drug Quality and Security Act (DQSA). Outsource Facilities must consent to greater federal oversight including more frequent inspections and are required to demonstrate their adherence to specific “good manufacturing practices.”

Avella Ranks Among the Nation's Best in the 2013 Cancer Awareness Advertising Awards Program
February 14, 2014| CATEGORIES: Oncology , Press Release

PHOENIX, February 14, 2014 – The Cancer Awareness Advertising Awards (CAAA) is the nation’s most elite competition recognizing excellence in advertising specific to Cancer Awareness.  As part of it’s mission, the CAAA recognizes and honors exceptional marketing, advertising and communications specifically for the promotion and education of cancer awareness.

Avella Specialty Pharmacy was recognized for excellence in the 2013 CAAA program for advertising and marketing efforts, which scored among the best in the nation.  Their white paper for oncology patients and healthcare provider won a Gold Award.  The full white paper can be found here: http://info.avella.com/oncology-whitepaper

Avella Announces Addition of Rebecca M. Shanahan to Senior Management Team
January 30, 2014| CATEGORIES: Corporate , Press Release

Avella Specialty Pharmacy, one of the nation’s largest and fastest growing independent specialty pharmacies, is proud to announce the addition of Rebecca M. Shanahan to its senior management team.  Ms. Shanahan brings over two decades of highly successful leadership experience in the healthcare sector, as well as 5 years of service on Avella’s Board of Directors, to her new role as the Company’s Chief Executive Officer.   John Musil, Pharm.D., FACA, the Company’s founder and CEO since inception, will continue to actively serve Avella as Chairman, focusing on long-term strategy and applying his unique combination of business expertise and pharmacist perspective as the Company’s ambassador to the clinical community. 

Avella Chosen as Preferred Specialty Pharmacy for Care1st Health Plan, Arizona
September 11, 2013| CATEGORIES: Corporate , Press Release

Avella Specialty Pharmacy today announced that it has been chosen as a preferred specialty pharmacy partner for Care1st Health Plan, Arizona. Care1st is a managed Medicaid health plan that contracts with MedImpact Healthcare Systems, Inc. for pharmacy benefit management services.

Avella Specialty Pharmacy Issues Voluntary Nationwide Recall of Two Medications Due to Concerns of Sterility Assurance at Testing Vendor
September 9, 2013| CATEGORIES: Corporate , Press Release

PHOENIX, September 9, 2013 – Avella Specialty Pharmacy is voluntarily recalling two compounded sterile medications. The recall is a result of concerns of sterility assurance with the specialty pharmacy’s independent testing laboratory, Front Range Laboratories.

News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe
News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe